June 29, 2026

FDA Approves New Treatment for Thyroid Eye Disease

Phase 3 THRIVE and THRIVE-2 trials supported approval following improvements in proptosis and diplopia in active and chronic disease.

Conexiant

May 29, 2026

FDA Monthly Preview: Key June Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

Conexiant

March 31, 2026

Equal Pay in Ophthalmology? Not Yet

A decade of AAMC salary data reveals a persistent gender pay gap in academic ophthalmology—and projects it will never close at senior ranks

Conexiant

February 25, 2026

FDA Approves First Therapy for Allergic Fungal Rhinosinusitis

Patients with allergic fungal rhinosinusitis now have a targeted biologic option.

Conexiant

February 18, 2026

Patterns of Spread in Ocular Melanoma

Study examines lymphatic and distant metastasis risk

Conexiant

February 13, 2026

UCI Health expands ENT and ophthalmology access

Newly opened UCI Health — Brea Outpatient Center increases access to academic-focused care

UCI Health

November 01, 2025

The Complex Difference of CAM

A look at the clinical applications and surgical techniques for cryopreserved amniotic membrane transplantation in oculoplastics.

Ophthalmology Management

August 26, 2025

FDA Begins Real-Time Reporting of Adverse Event Data

According to the FDA, the shift is one of many steps in the agency’s broader data modernization strategy to streamline all of its adverse event reporting systems and increase reporting frequency across all systems to identify safety signals faster.

Ophthalmology Management

August 26, 2025

FDA Begins Real-Time Reporting of Adverse Event Data

According to the FDA, the shift is one of many steps in the agency’s broader data modernization strategy to streamline all of its adverse event reporting systems and increase reporting frequency across all systems to identify safety signals faster.

Ophthalmology Management

August 17, 2025

FDA Affirms Safety of PFAS-Based Materials in Medical Devices

PFAS used in medical devices are different from the small-molecule PFAS that have been linked to environmental and health concerns.

Contact Lens Spectrum